Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average): 2013-2016

Historic Shares Outstanding (Diluted Average) for Amphastar Pharmaceuticals (AMPH) over the last 3 years, with Jun 2016 value amounting to $46.0 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) rose 2.50% to $46.0 million in Q2 2016 from the same period last year, while for Jun 2016 it was $46.0 million, marking a year-over-year increase of 2.50%. This contributed to the annual value of $45.0 million for FY2015, which is 7.16% up from last year.
  • According to the latest figures from Q2 2016, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) is $46.0 million, which was down 1.80% from $46.8 million recorded in Q1 2016.
  • In the past 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $46.8 million in Q1 2016 and a low of $38,769 during Q1 2014.
  • For the 3-year period, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $26.9 million, with its median value being $43.3 million (2014).
  • In the last 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) slumped by 99.90% in 2014 and then soared by 114,942.95% in 2015.
  • Over the past 4 years, Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarterly) stood at $38.9 million in 2013, then grew by 7.91% to $42.0 million in 2014, then rose by 7.16% to $45.0 million in 2015, then rose by 2.50% to $46.0 million in 2016.
  • Its Shares Outstanding (Diluted Average) was $46.0 million in Q2 2016, compared to $46.8 million in Q1 2016 and $45.0 million in Q4 2015.